Archive for June, 2020
On July 1, New Jersey is slated to reduce the sales tax on medical marijuana from 6.625% to 4%. This move is the first in a series of measures that will see state sales taxes removed entirely within a space of three years. On July 1 next year, the tax will reduce to 2% and the following year (July 1, 2022) will see the reduction to a 0% state sales tax.
However, the sales tax reforms which roll out tomorrow don’t mean that buyers of medical marijuana will not pay any taxes on their purchases. Municipalities within New Jersey are still allowed to impose a 2% sales tax within their jurisdictions, but so far, no town has invoked this provision to levy the tax.
The plan to phase out sales taxes on medical marijuana were part of the Jake Honig Compassionate Use Act enacted into law last year. The bill was named after Jake Honig, a 7-year old kid from Howell who had an inoperable tumor in the brain. Only medical marijuana gave him any relief until he passed in 2018.
Activists raised an uproar about the sales taxes imposed by the state on medical marijuana. This outcry was prompted by the fact that prescription medications are exempted from state sales tax. The activists therefore wanted medical marijuana to be regarded in the same way since it is a prescription medicine in New Jersey.
While the bill was being debated in the state legislature, several lawmakers called the sales tax “criminal” since working class and poor families would suffer an added burden while acquiring the medicine they need.
Currently, more than 77,000 people are registered on the state’s medical marijuana program. However, supply chain problems and the resulting prohibitive prices (medical marijuana can cost approximately $500 an ounce) have plagued the progress of the sector.
As the tax cuts kick in, an ounce of medical marijuana will drop to about $469.15. This will bring some relief to patients, and as the supply issues are sorted, prices could drop even further.
At the moment, only nine clinics are open to sell medical pot to patients across the state. Other locations that were pre-approved haven’t opened their doors to customers due to ongoing legal battles.
In November, New Jersey voters are slated to vote on a ballot measure that could see recreational marijuana legalized. If the bill passes, dispensaries will be allowed to sell recreational marijuana to adults who are 21 or older.
The reduction of the state sales tax on medical marijuana is likely to be welcomed by the entire industry, including Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) since it makes products more affordable for patients.
About CNW420
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CNW420.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have questions or are you interested in working with CNW420? Ask our Editor
CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CNW420 is part of the InvestorBrandNetwork.
Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, on Monday announced the closing of its previously announced transaction. According to the update, Predictive Oncology secured approximately $2.2 million in gross cash proceeds from the transaction, prior to deducting placement agent fees and offering expenses, through the exercise of certain existing warrants by several holders to purchase an aggregate of up to 1,396,826 shares of common stock, each at an exercise price of $1.575. The shares of common stock issued upon exercise of the existing warrants are registered for resale pursuant to a registration statement on Form S-1 (File No. 333-239207). The Company intends to use the net proceeds from the offering for working capital and general corporate purposes.
To view the full press release, visit http://nnw.fm/0SJ0o
About Predictive Oncology Inc.
Predictive Oncology (NASDAQ: POAI) operates through three segments (Domestic, International and other), which contain four subsidiaries; Helomics, TumorGenesis, Skyline Medical and Skyline Europe. Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. Helomics’ CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based roadmap for therapy. In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor(TM), patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary bioinformatics platform to provide a tailored solution to its clients’ specific needs. Predictive Oncology’s Skyline Medical division markets its patented and FDA cleared STREAMWAY System, which automates the collection, measurement and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions. The company has achieved sales in five of the seven continents through both direct sales and distributor partners. For more information, please visit www.Predictive-Oncology.com.
NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://nnw.fm/POAI
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
NetworkNewsWire is part of the InvestorBrandNetwork.
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences and other industries, today announced its entry into a worldwide co-marketing agreement with German-based Leica Microsystems CMS GmbH, a Danaher company. Per the update, the historic alliance is expected to offer transformative new empowerment to cancer research worldwide through integrating the latest enabling technologies in capturing, isolating and preparing biopsy samples for superior analysis of relevant biomarkers of disease state and treatment response. “The generation of reliable and reproducible data from biopsy samples is difficult, as it requires the integration of multiple and varied laboratory processes, particularly tissue extraction, sample preparation, and analysis,” Roxana McCloskey, PBI’s Global Director of Sales & Marketing, stated in the news release. “The innovative LMD-PCT workflow enables the reproducible and rapid extraction of proteins from precious clinical samples by combining the precision of the Leica LMD system with PBI’s versatile PCT sample preparation platform. The ability to co-market the workflow offers the opportunity for the combined sales and marketing forces of Leica and PBI to extend the integrated LMD-PCT systems into additional research centers globally that are focused on clinical proteomics, cancer research, biomarker discovery, and precision medicine.”
To view the full press release, visit http://nnw.fm/38KYp
About Pressure BioSciences, Inc.
Pressure BioSciences, Inc. (OTCQB: PBIO) is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences and other industries. Its products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or PCT) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control biomolecular interactions safely and reproducibly (e.g., cell lysis, biomolecule extraction). The company’s primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil & plant biology, forensics, and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of its pressure-based technologies in the following areas: (1) the use of recently acquired, patented technology from BaroFold, Inc. (the “BaroFold” technology) to allow entry into the bio-pharma contract services sector, and (2) the use of recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. For more information, visit www.PressureBioSciences.com.
NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://nnw.fm/PBIO
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
NetworkNewsWire is part of the InvestorBrandNetwork.
iClick Interactive Asia Group (NASDAQ: ICLK), an independent online marketing and enterprise data solutions provider in China, today announced that it has been named winner of the Big Data Award in the advertising category at Singapore Business Review’s (“SBR”) second Technology Excellence Awards 2020. Held annually by SBR, a leading business magazine serving Singapore’s dynamic business community, the Technology Excellence Awards recognize outstanding companies worldwide that have made exceptional contributions in pursuit of technological innovation. “We are thrilled to receive this award from Singapore Business Review which further recognizes iClick’s leadership in the international digital marketing industry,” Jian “T.J.” Tang, iClick’s CEO and co-founder, stated in the news release. “Drawing on our cutting-edge technologies and robust data resources, iClick will persist in our mission to relentlessly develop and upgrade our intelligent marketing solutions to help global clients build presence and successfully fuel growth in China with the best and the most efficient data-driven, one-stop marketing solutions, as we continue our evolution into a fully integrated marketing and enterprise cloud platform.”
To view the full press release, visit http://nnw.fm/jQFM1
About iClick Interactive Asia Group Limited
iClick Interactive Asia Group Limited (NASDAQ: ICLK) is an independent online marketing and enterprise data solutions provider that connects worldwide marketers with audiences in China. Built on cutting-edge technologies, its proprietary platform possesses omni-channel marketing capabilities and fulfils various marketing objectives in a data-driven and automated manner, helping both international and domestic marketers reach their target audiences in China. Headquartered in Hong Kong, iClick was established in 2009 and is currently operating in ten locations worldwide including Asia and Europe.
For more information, please visit ir.i-Click.com.
NOTE TO INVESTORS: The latest news and updates relating to ICLK are available in the company’s newsroom at http://nnw.fm/ICLK
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
NetworkNewsWire is part of the InvestorBrandNetwork.
NetworkNewsWire Editorial Coverage: Despite lockdowns, creative data analytics and digital marketing deliver incredible results.
As the nation’s economy slammed shut due to the pandemic, certain sectors seemed to defy the severity of the situation. The digital world seemed to defy gravity, generating ever more interest and expediting uptake out of necessity. A recent press release from SRAX Inc. (NASDAQ: SRAX) (SRAX Profile) is a prime example of such gravity-defying action and may be a harbinger of what’s to come. Leveraging in-depth investor intelligence and big data analytics, SRAX uses proprietary technology to creatively unlock and utilize data in new powerful ways to create a new nexus of opportunity between public companies, financiers, investors and traders. SRAX just released news on Sequire, the company’s innovative technology platform for comprehensive investor intelligence, corporate communications and shareholder retention and acquisition. From launch just over a year ago, Sequire has grown its client base to over 75 publicly traded companies, amassing an aggregate 500,000+ active investors and traders as sales have exploded in Q2 2020. What makes Sequire so attractive with such rapid uptake is that for the first-time public companies can monitor investors and activate media campaigns to engage existing investors and attract new ones. SRAX’s technology delivers public companies unparalleled insights into investors’ behaviors and trends and newfound ability to use those insights to engage investors across various marketing channels. Leveraging data and resources from Broadridge Financial Solutions Inc. (NYSE: BR), a leading provider of communications and data and analytics solutions, Sequire has attracted public companies across a wide spectrum of industries and delivered notable results from its platform for such diverse companies as Genius Brands International Inc. (NASDAQ: GNUS), a children’s entertainment media company; Can B Corp. (OTCQB: CANB) a health & wellness company; and Wrap Technologies Inc. (NASDAQ: WRTC), an innovator of modern policing solutions.
Accelerated Uptake
The adoption of technology and the digitization of business has been underway for decades. Changes were evolving long before coronavirus, but the pandemic hypersonically accelerated the evolution. Companies that were obliquely considering digital solutions a few years ago are now embracing them as part of the new normal, establishing business relationships for a long-term digital future. Whether through Zoom meetings, virtual conferences or digital marketing, companies in nearly every industry are pivoting to adapt to the crisis. The virus has hastened the digital transition so fast that customers across every sector are flocking to technology solutions as digital platforms reap the benefits. This transition to technology is no passing fad and is expected to permanently alter the way business is conducted and social interactions occur. Nowhere is this transition more needed or welcomed than in the complex interactions between public companies and their current and future shareholders. Roadshows and investor conferences are suddenly lumbering dinosaurs while virtual meetings lack sizzle and have limited appeal. Innovative new strategies and creative big data solutions are at the heart of establishing a new paradigm in investor intelligence, and corporate communications and will set the standard for decades to come.
Data Centric Solutions
It’s a common understanding that data is collected and analyzed, but data alone is useless until it’s been parsed and massaged in some manner to create actionable intelligence. The optimization and monetization of data is a multibillion-dollar global business – data and business analytics solutions reached $166 billion in 2018, and it is projected to explode to $260 billion in just two years. SRAX (NASDAQ: SRAX) (SRAX Profile), a rapidly growing, innovative consumer data management technology company, is carving an enviable niche in this explosive market. SRAX uniquely unlocks the value of data, integrating all aspects of the digital marketing and advertising experience, including verified consumer participation, all into one platform. Through its Sequire technology platform, SRAX is monetizing datasets and growing recurring revenue streams by delivering a digital competitive advantage for clients. Recent news at Sequire offers crystal clear insight into the company’s parabolic growth potential. Using proprietary processes, unique data management technology and digital marketing acumen, Sequire has experienced incredible growth from its launch just over a year ago, expanding its client base to over 75 publicly traded companies in the U.S. and Canada. Sequire posted record sales of over $2.5M in Q2 2020, servicing an aggregate of 500K+ investors and traders that issuers have on the platform. These ballooning numbers indicate an accelerated uptake of Sequire’s unique investor relations services, long a stumbling block for publicly traded companies.
Some of this accelerated uptake may be attributed to the pandemic, but platform efficacy is paramount – clients come and stay because it works, delivering new digital competitive advantages. Through Sequire, public companies can now monitor and track retail and institutional investors then activate media campaigns to engage existing investors and simultaneously attract new ones. Sequire can identify traits of current investors and is then able to market directly to subgroups to attract liked minded shareholders. Public companies never had it so good, especially ones providing niche products services. This has long been the bane of public companies – how to effectively interact and communicate with current shareholders and—even more importantly—how to appeal to and attract new shareholders. Never before has such an effective solution been provided to the investor relations dilemma faced by publicly traded companies.
This news comes on the heels of last week’s eyepopping revelation that SRAX had entered into a definitive securities purchase agreement led by existing institutional investors for the purchase and sale of an aggregate of $13 million senior secured convertible debentures to fund the rapid expansion of Sequire. Pegged at an above-market fixed conversion price of $2.69, the deal appears to be another strong vote of confidence from institutional investors in the viability and future of SRAX’s technology as well as an endorsement of the market value of data analytics and digital marketing.
“On Thursday, we announced a capital raise of $13M, which we will use in part to fund the rapid expansion of Sequire,” said SRAX CEO and founder Christopher Miglino. “Our clients have seen notable results from the platform and its related services. We’ve also seen a significant increase in the number of clients on the platform with Q2 sales hitting over $2.5M and an additional $3M in the pipeline, with a very high probability of closing in Q3.”
To translate, Sequire has a high probability of reaching a 200% quarter-over-quarter increase in sales in the midst of a crippling global pandemic – hard to imagine any stronger validation of efficacy and accelerated uptake of SRAX’s technology and services.
In new powerful ways, public companies using Sequire now track their investors’ behaviors and trends and use those insights to engage current and potential investors across multiple marketing channels. By uniquely marrying data management and digital marketing, Sequire unlocks investor behaviors and trends, even providing public companies the ability to identify who is buying and selling stock. Then, using these newfound detailed insights, these companies can pique and capture the interest of existing investors as well as attract new investors.
Sequire gives public companies the power to:
- Monitor shareholders’ behaviors from a company’s data sets over time
- Analyze activity from market makers and see the biggest gains and losses
- Uncover trends over time from buyer and sellers
- Track ROI from investor relations programs
- Assign shareholder credit to investor relations firms
- Turn real-time conference visitor data into targeted cross-channel ads
- Reach potential investors based on current stock buyer behaviors and trends
- Target current stock buyers to promote a higher return from existing relationships
Putting power into finger tips, Sequire also offers an multi-feature innovative mobile APP and more information can be found at MySequire.com.
SRAX has an extensive background and acumen in data management and digital advertising as well as deep understanding how to strategically interact with different brands. The rapid acceptance and adoption of SRAX’s product offering in the midst of a pandemic, strong institutional investor support, and the accelerated embracement of digital solutions definitely makes SRAX one to watch.
Just a Few of a Growing Number
Broadridge Financial Solutions, Inc. (NYSE: BR) is a $4 billion global fintech leader, provides investor communications and technology-driven solutions for broker-dealers, banks, mutual funds and corporate issuers globally. Broadridge’s investor communications, securities processing and managed services solutions help clients reduce their capital investments in operations infrastructure, allowing them to increase their focus on core business activities.
Genius Brands International, Inc. (NASDAQ: GNUS) is a leading global media company that develops, produces, markets and licenses branded children’s entertainment properties and consumer products for media and retail distribution. The company distributes its content worldwide in all formats, as well as a broad range of consumer products based on its characters. The Genius Brands Network currently reaches 80 million U.S. households with continued expansion planned both in the U.S. and internationally.
Wrap Technologies, Inc. (NASDAQ: WRTC) is an innovator of modern policing solutions. The company’s BolaWrap product is a patented, hand-held remote restraint device that discharges an 8-foot bola style Kevlar(R) tether to entangle an individual at a range of 10-25 feet. The small but powerful BolaWrap 100 assists law enforcement to control encounters safely and effectively.
Can B Corp. (OTCQB: CANB) is a health & wellness company providing some of the highest grade and purity cannabidiol (CBD) products available under multiple recognized brands. “Sequire is an essential tool for any CEO to understand what is going on with their stock and for their ability to communicate with their investors and find new ones,” said Can B Corp. CEO Marco Alfonsi. Can B utilizes multi-channel distribution to reach consumers, including medical facilities, doctor offices, retailers, online and direct. The company owns and operates an R&D and production facility in Lacey, WA, and Green Grow Farms, a licensed hemp grower and cultivator in New York.
For more information on SRAX Inc., please visit SRAX Inc. (NASDAQ: SRAX).
About NetworkNewsWire
NetworkNewsWire (“NNW”) is a financial news and content distribution company, one of 40+ brands within the InvestorBrandNetwork (“IBN”), that provides: (1) access to a network of wire solutions via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions to ensure maximum impact; (4) social media distribution via IBN millions of social media followers; and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience comprising investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
NetworkNewsWire is part of the InvestorBrandNetwork
DISCLAIMER: NetworkNewsWire (NNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by NNW are solely those of NNW. Readers of this Article and content agree that they cannot and will not seek to hold liable NNW for any investment decisions by their readers or subscribers. NNW is a news dissemination and financial marketing solutions provider and are NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.
The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, NNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.
NNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and NNW undertakes no obligation to update such statements.
Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) on Friday announced the expiration of the forbearance period (“Forbearance Period”) pursuant to the terms of the forbearance agreement (the “Forbearance Agreement”) with Green Ops Group LLC (“Green Ops”) previously announced on May 20, 2020. Per the update, the expiration of the Forbearance Period entitles Green Ops to exercise any and all of its rights under the loan documents and applicable law, and GGB is precluded from contesting any such enforcement action under a separate Voluntary Surrender of Collateral in Satisfaction of Debt and Release Agreement among the parties.
To view the full press release, visit http://cnw.fm/uNA9H
About Green Growth Brands Inc.
Green Growth Brands creates remarkable experiences in cannabis. The company’s brands include CAMP, The+Source and 8 Fold. GGB is continuing its cannabis operations throughout the U.S., via dispensaries in Nevada and Massachusetts. Learn more about the vision at GreenGrowthBrands.com.
NOTE TO INVESTORS: The latest news and updates relating to GGBXF are available in the company’s newsroom at http://cnw.fm/GGBXF
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CannabisNewsWire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have questions or are you interested in working with CNW? Ask our Editor
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CannabisNewsWire is part of the InvestorBrandNetwork.
MINNEAPOLIS, June 29, 2020 — Predictive Oncology Inc. (the “Company,” “Predictive Oncology,” “we,” “our” or “us”) (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced the closing of its previously announced transaction resulting in gross cash proceeds to the Company of approximately $2.2 million, prior to deducting placement agent fees and offering expenses, through the exercise of certain existing warrants by several holders to purchase an aggregate of up to 1,396,826 shares of common stock at an exercise price of $1.575 per share. The shares of common stock issued upon exercise of the existing warrants are registered for resale pursuant to a registration statement on Form S-1 (File No. 333-239207).
In consideration for the immediate exercise of the existing warrants for cash, the exercising holders received new unregistered warrants to purchase up to an aggregate of 1,396,826 shares of common stock at an exercise price of $1.80 per share with an exercise period of five and one-half years from the date of issuance.
The Company expects to use the net proceeds from this offering for working capital and general corporate purposes.
H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.
The new warrants described above were offered in a private placement pursuant to an applicable exemption from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”), and, along with the shares of common stock issuable upon the exercise thereof, have not been registered under the Securities Act, and may not be offered or sold in the United States absent registration with the Securities and Exchange Commission or an applicable exemption from such registration requirements. The securities were offered only to accredited investors. The Company has agreed to file one or more registration statements with the Securities and Exchange Commission covering the resale of the shares of common stock issuable upon exercise of the warrants.
This press release shall not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction.
About Predictive Oncology Inc.
Predictive Oncology (NASDAQ: POAI) operates through three segments (Domestic, International and other), which contain four subsidiaries; Helomics, TumorGenesis, Skyline Medical and Skyline Europe. Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. Helomics’ CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based roadmap for therapy. In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor™, patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary bioinformatics platform to provide a tailored solution to its clients’ specific needs. Predictive Oncology’s TumorGenesis subsidiary is developing a new rapid approach to growing tumors in the laboratory, which essentially “fools” cancer cells into thinking they are still growing inside a patient. Its proprietary Oncology Discovery Technology Platform kits will assist researchers and clinicians to identify which cancer cells bind to specific biomarkers. Once the biomarkers are identified they can be used in TumorGenesis’ Oncology Capture Technology Platforms which isolate and help categorize an individual patient’s heterogeneous tumor samples to enable the development of patient specific treatment options. Helomics and TumorGenesis are focused on ovarian cancer. Predictive Oncology’s Skyline Medical division markets its patented and FDA cleared STREAMWAY System, which automates the collection, measurement and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions. The company has achieved sales in five of the seven continents through both direct sales and distributor partners. For more information, please visit www.Predictive-Oncology.com.
Forward-Looking Statements
Certain of the matters discussed in this press release, including the intended use of the proceeds from the transaction described herein, are forward-looking statements that involve material risks to and uncertainties in the Company’s business that may cause actual results to differ materially from those anticipated by the statements made herein. Such risks and uncertainties include: we may not be able to continue operating without additional financing; current negative operating cash flows; the terms of any further financing, which may be highly dilutive and may include onerous terms; risks related to the 2019 merger with Helomics including; 1) significant goodwill could result in further impairment; 2) possible failure to realize anticipated benefits of the merger; 3) costs associated with the merger may be higher than expected; 4) the merger may result in the disruption of our existing businesses; and 5) distraction of management and diversion of resources; risks related to our partnerships with other companies, including the need to negotiate the definitive agreements; possible failure to realize anticipated benefits of these partnerships; and costs of providing funding to our partner companies, which may never be repaid or provide anticipated returns; risks related to the transaction with Quantitative Medicine including: 1) completion of the transaction; 2) possible failure to realize anticipated benefits of the merger; 3) costs associated with the merger may be higher than expected; 4) the merger may result in the disruption of our existing businesses; and 5) distraction of management and diversion of resources; risk that we will be unable to protect our intellectual property or claims that we are infringing on others’ intellectual property; the impact of competition; acquisition and maintenance of any necessary regulatory clearances applicable to applications of our technology; inability to attract or retain qualified senior management personnel, including sales and marketing personnel; risk that we never become profitable if our product is not accepted by potential customers; possible impact of government regulation and scrutiny; unexpected costs and operating deficits, and lower than expected sales and revenues, if any; adverse results of any legal proceedings; the volatility of our operating results and financial condition; and management of growth. In addition, our business and operations have been and will likely continue to be materially and adversely affected by the COVD-19 pandemic, including impact on a significant supplier; a reduction in on-site staff at several of our facilities, resulting in delayed production and less efficiency; impact on sales efforts; impact on accounts receivable and terms demanded by suppliers; and possible impact on financing transactions; resulting in a possible continued material adverse effect on our business, financial condition and results of operations. These and other risks and uncertainties may be detailed from time to time in the Company’s reports filed with the SEC, which are available for review at www.sec.gov.
Investor Relations Contact:
Hayden IR
James Carbonara
(646)-755-7412
james@haydenir.com
- Trxade Group Inc. facilitates the procurement and delivery of prescription drugs to a growing network of independent pharmacies, positioning them to compete with much larger national chains
- Trxade’s healthtech platform facilitates remote-access patient-provider consultations through its developing Bonum Health Hub smart technology-optimized services, which proves particularly useful during the present pandemic
- The company is slated to be included in the Russell Microcap Index when Russell’s annual index reconstitution is completed by month’s end
- Inclusion in the Russell index, as well as the recent undertaking of research report coverage by investment services firm Taglich Brothers, and the company’s uplisting to the NASDAQ market in February are helping Trxade to build its investor profile
Prescription drug procurement and healthcare services innovator Trxade Group (NASDAQ: MEDS), is celebrating another benchmark in its growth strategy following the announcement it will be included in Russell’s Microcap Index when the global index powerhouse completes the annual reconstitution of its market index measurements of the largest U.S. stocks by category following the market close on June 26, going into effect as markets open Monday, June 29 (http://nnw.fm/f2AEC).
FTSE Russell calculates thousands of indexes that measure and benchmark markets and asset classes in more than 70 countries, covering 98 percent of the investable market globally, and Russell’s indexes have been used for over 30 years by asset owners and managers to judge their investments’ performance and make investment product decisions.
Trxade Group has been nurturing a healthtech brand that values affordability, transparency and equal access to medical community patients by expanding its network of independent pharmacies and empowering them to better deliver medications through the effective use of technology.
Investment analysis media outlet Alphastreet recently noted that the rise in online pharmaceutical purchasing over the past decade and the heightened attention to remote-access medical care brought on by the present coronavirus pandemic are positioning Trxade’s independent pharmacies to compete with bigger healthcare retailers such as CVS Health or Walgreens Boots Alliance (http://nnw.fm/Ui4Yr).
After its acquisition of Internet drug outlet company Community Specialty Pharmacy, LLC, two years ago (http://nnw.fm/4cVb3), Trxade was able to advance its prescription drug distribution platform and add a “Health Hub” virtual examination platform via technology for private, secure patient-physician consultations last year (http://nnw.fm/33g9O), which helped drive the company’s stock uplisting on The NASDAQ Capital Market in February (http://nnw.fm/WI2en).
“In the retrospect, Trxade ticks three requirements that value investors look for in stocks: a comfortable balance sheet, the ability to make profits and plenty of headroom for growth,” Alphastreet stated.
Trxade’s addition to the Russell Microcap Index helps the integrated drug and healthcare platform raise its profile among the investment community, furthering its potential to generate long-term shareholder value while limiting marketing expenses.
“This marks an exciting capital markets milestone in the growth and trajectory of our company as we continue to execute upon our growth strategy and raise awareness about the Company throughout the investment community,” Trxade Chairman and CEO Suren Ajjarapu stated in the news release about the Russell listing.
About $9 trillion in assets are benchmarked against Russell’s US indexes, according to the news release.
Ajjarapu appeared in a webinar presentation June 24 to provide an overview of the company’s business model and growth initiatives. A replay of the webinar can be viewed at http://nnw.fm/Boz14 or by dialing 1-844-512-2921 within the United States, or 1-412-317-6671 from international locations, and entering replay pin number 13705066 through July 8.
For more information, visit the company’s website at www.TrxadeGroup.com.
NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://nnw.fm/MEDS
About NetworkNewsWire
NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
NetworkNewsWire is part of the InvestorBrandNetwork.
SRAX (NASDAQ: SRAX), a digital marketing and consumer data management technology company, today announced that its investor intelligence and communications platform, Sequire, has surpassed 500,000 active investors and traders while sales have exceeded $2.5 million in Q2 2020. According to the update, Sequire has shown rapid growth since its early 2019 launch, expanding its client base to over 75 publicly traded companies in the U.S. and Canada. “On Thursday, we announced a capital raise of $13M, which we will use in part to fund the rapid expansion of Sequire,” Christopher Miglino, founder and CEO of SRAX, stated in the news release. “Our clients have seen notable results from the platform and its related services. We’ve also seen a significant increase in the number of clients on the platform with Q2 sales hitting over $2.5M and an additional $3M in the pipeline, with a very high probability of closing in Q3.”
To view the full press release, visit http://nnw.fm/8aTrG
About SRAX
SRAX (NASDAQ: SRAX) is a digital marketing and consumer data management technology company. SRAX’s technology unlocks data for brands in the CPG, investor relations, luxury, and lifestyle verticals. Through its various platforms, SRAX is monetizing its data sets and growing multiple recurring revenue streams. BIGtoken is a consumer-managed data marketplace where people can own and earn from their data. The platform also provides advertisers and media companies access to transparent, verified consumer data to better reach and serve audiences. Sequire is a premier platform for investor intelligence and communication. Through Sequire, public companies can track their investors’ behaviors and trends and use those insights to engage current and potential investors across marketing channels. For more information on SRAX and its verticals, visit www.SRAX.com.
NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://nnw.fm/SRAX
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
NetworkNewsWire is part of the InvestorBrandNetwork.
Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, today announced that it was added to the Russell 3000(R) Index after the market closed on Friday, June 26, 2020 as part of the 2020 Russell U.S. Indexes reconstitution. “Genprex is excited to be a member of the Russell 3000 Index, and we look forward to sharing our story and unique approaches for the treatment of lung cancer and diabetes with a wider group of investors,” Rodney Varner, chairman and CEO of Genprex, stated in the news release. “We believe the Company’s future is bright as we work to secure better outcomes for patients suffering from these serious medical conditions.”
To view the full press release, visit http://nnw.fm/e9fTg
About Genprex, Inc.
Genprex, Inc. is a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes. Genprex’s technologies are designed to administer disease-fighting genes to provide new treatment options for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex works with world-class institutions and collaborators to in-license and develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches. The Company’s lead product candidate, Oncoprex(TM), is being evaluated as a treatment for non-small cell lung cancer (“NSCLC”). Oncoprex has a multimodal mechanism of action that has been shown to interrupt cell signaling pathways that cause replication and proliferation of cancer cells; re-establish pathways for apoptosis, or programmed cell death, in cancer cells; and modulate the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance. In January 2020, the U.S. Food and Drug Administration granted Fast Track Designation for Oncoprex immunogene therapy for NSCLC in combination therapy with osimertinib (AstraZeneca’s Tagrisso(R)) for patients with EFGR mutations whose tumors progressed after treatment with osimertinib alone. For more information, please visit the company’s website at www.Genprex.com
NOTE TO INVESTORS: The latest news and updates relating to GNPX are available in the company’s newsroom at http://nnw.fm/GNPX
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
NetworkNewsWire is part of the InvestorBrandNetwork.
Jerrick Media Holdings (OTCQB: JMDA), a technology company and the parent company of Vocal, today announced the appointment of three new executives to its leadership team. According to the update, the Company named Chelsea Pullano as chief financial officer (“CFO”), effective immediately. In addition, upon Jerrick’s planned NASDAQ uplisting this summer, Danielle Banner will be formally named chief revenue officer (“CRO”) and Robby Tal as chief strategy officer (“CSO”). “As we head into our shareholder meeting, we have assembled the right team to manage our transition from the OTCQB to the NASDAQ Capital Markets,” Jerrick’s president and Head of Product Justin Maury stated in the news release. “With the combined strength of our employees as a whole, and with Officers of the high caliber that Chelsea, Danielle, and Robby represent, our team represents the ideal collective to execute on both our product expansion and our corporate vision.”
To view the full press release, visit http://nnw.fm/KzM2v
About Jerrick
Jerrick Media Holdings, Inc. is the parent company and creator of the Vocal platform. The Company creates technology-based solutions to solve problems for the creative community. Through Vocal, Jerrick identifies and leverages opportunities within the digital platform and content monetization space. Since launching in 2016, Vocal has become home to over 600,000 content creators and brands of all shapes and sizes, attracting audiences across its network of wholly owned and operated communities. For more information, visit the Company’s website at https://Jerrick.media.
NOTE TO INVESTORS: The latest news and updates relating to JMDA are available in the company’s newsroom at http://nnw.fm/JMDA
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
NetworkNewsWire is part of the InvestorBrandNetwork.
Wrap Technologies (NASDAQ: WRTC), an innovator of modern policing solutions, today announced its receipt of a new follow-on order for 21,600 additional BolaWrap cartridges for the Indonesia National Police force. The Company previously reported the fulfillment of an initial order of devices and cartridges placed by its distributor in Indonesia at the end of 2019. Following successful BolaWrap demonstrations across the country, the Company’s distributor recently secured a contract with the Indonesian National Police force. “We are very pleased to see both new international orders and follow-on orders such as this one for a major police force,” Tom Smith, president at Wrap Technologies, stated in the news release. “We believe this order reflects the Indonesian National Police force’s acceptance of the BolaWrap as a viable solution to an age-old challenge in policing – safely detaining noncompliant subjects without injury.”
To view the full press release, visit http://nnw.fm/h1EYl
About Wrap Technologies (NASDAQ: WRTC)
Wrap Technologies is an innovator of modern policing solutions. The Company’s BolaWrap 100 product is a patented, hand-held remote restraint device that discharges an eight-foot bola style Kevlar(R) tether to restrain an individual at a range of 10-25 feet. Developed by award winning inventor Elwood Norris, the Company’s Chief Technology Officer, the small but powerful BolaWrap 100 assists law enforcement to safely and effectively control encounters, especially those involving an individual experiencing a mental crisis. For information on the Company please visit www.WrapTechnologies.com. Examples of recent media coverage are available as links under the “Media” tab of the website.
NOTE TO INVESTORS: The latest news and updates relating to WRTC are available in the company’s newsroom at http://nnw.fm/WRTC
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
NetworkNewsWire is part of the InvestorBrandNetwork.
Predictive Oncology (NASDAQ: POAI), through its Helomics subsidiary, is providing clinical decision support tools to support oncologists in personalizing cancer treatment. A recent article discussing the company further reads, “Through its unique patient derived (PDx) platform, which tests the drug response and biomarker profile of the patient’s own tumor, and its vast database of historical tumor profiles, Helomics provides clinical decision support tools today to assist oncologists in individualizing cancer treatment. . . . Precision medicine is based on the idea of customizing health care, making medical decisions and selecting treatments, practices and prescriptions that are tailored to each individual patient rather than a recommended general treatment approach. A recent Acumen Research and Reporting article noted that the global precision medicine market is expected to reach total market value of approximately $84 billion by 2026 with anticipated CAGR growth of around 10% in terms of revenue between 2019 and 2026 (http://nnw.fm/tQAG2).”
To view the full article, visit http://nnw.fm/ixH1H
About Predictive Oncology Inc.
Predictive Oncology operates through three segments (domestic, international and other), which contain four subsidiaries; Helomics, TumorGenesis, Skyline Medical and Skyline Europe. Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. Helomics’ CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient-treatment decisions, by providing an evidence-based road map for therapy. In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor(TM), patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary bioinformatics platform to provide a tailored solution to its clients’ specific needs. Predictive Oncology’s Skyline Medical division markets its patented and FDA cleared STREAMWAY System, which automates the collection, measurement and disposal of waste fluid including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions. The company has achieved sales in five of the seven continents through both direct sales and distributor partners. For more information, please visit www.Predictive-Oncology.com.
NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://nnw.fm/POAI
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
NetworkNewsWire is part of the InvestorBrandNetwork.
COLUMBUS, Ohio, June 26, 2020 – Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) (“GGB” or the “Company“) announced today the expiry of the forbearance period (“Forbearance Period”) pursuant to the terms of the forbearance agreement (the “Forbearance Agreement”) with Green Ops Group LLC (“Green Ops”) previously announced on May 20, 2020. The expiration of the Forbearance Period entitles Green Ops to exercise any and all of its rights under the loan documents and applicable law, and GGB is precluded from contesting any such enforcement action under a separate Voluntary Surrender of Collateral in Satisfaction of Debt and Release Agreement among the parties. The Company has also received a letter from legal counsel to Green Ops notifying the Company of the acceleration of all secured obligations of the Company under the Forbearance Agreement and that all guaranteed obligations of the Company owing to Green Ops are immediately due and payable in full. The Company has been notified that Green Ops intends to enforce its righs under such loan documents and applicable law through the seizure of collateral granted by the Company and the Grantors (as defined in the Forbearance Agreement).
About Green Growth Brands Inc.
Green Growth Brands creates remarkable experiences in cannabis. The company’s brands include CAMP, The+Source, and 8 Fold. GGB is continuing its cannabis operations throughout the U.S., via dispensaries in Nevada and Massachusetts. Learn more about the vision at GreenGrowthBrands.com.
For investor relations inquiries, please contact:
Randy Whitaker
Chief Executive Officer
Green Growth Brands Inc.
rwhitaker@greengrowthbrands.com
1-800-282-8462
Energy Fuels (NYSE American: UUUU) (TSX: EFR), the leading uranium producer in the United States, recently finalized consulting agreements with two rare earth element (“REE”) industry experts, Constantine Karayannopoulos and Brock O’Kelley. The experts will consult with the company on the development and implementation of commercial and technical REE strategies for the new U.S. REE program (http://nnw.fm/z82zF). An article discussing the company reads, “The company previously announced that it is entering the U.S. rare earths space by potentially leveraging its existing White Mesa Mill in Utah to produce high-value rare earth concentrates. If successful, the mill would play a critical role in restoring a U.S. rare earths supply chain. . . . ‘Energy Fuels is extremely excited to bring Constantine Karayannopoulos and Brock O’Kelley on board to advance our entry into the rare earth space in the U.S.,’ UUUU president and CEO Mark S. Chalmers stated in a news release. ‘Over the past year or so, Energy Fuels has been actively evaluating this rare earth opportunity. We are quickly coming to the conclusion that the White Mesa Mill may be an ideal U.S. facility to process rare earth element ore streams and produce rare earth concentrates. Mr. Karayannopoulos and Mr. O’Kelley will assist Energy Fuels in the commercial and technical aspects of this endeavor.’”
To view the full article, visit http://nnw.fm/I816b
About Energy Fuels
Energy Fuels is a leading U.S.-based uranium mining company, supplying U3O8 to major nuclear utilities. The company also produces vanadium from certain of its projects, as market conditions warrant. Its corporate offices are near Denver, Colorado, and all of its assets and employees are in the United States. Energy Fuels holds three of America’s key uranium production centers: the White Mesa Mill in Utah, the Nichols Ranch in-situ recovery (“ISR”) Project in Wyoming and the Alta Mesa ISR Project in Texas. The White Mesa Mill is the only conventional uranium mill operating in the United States today, has a licensed capacity of over 8 million pounds of U3O8 per year, and has the ability to produce vanadium when market conditions warrant. The Nichols Ranch ISR Project is on standby and has a licensed capacity of 2 million pounds of U3O8 per year. The Alta Mesa ISR Project is also currently on standby. In addition to the above production facilities, Energy Fuels has one of the largest NI 43-101 compliant uranium resource portfolios in the U.S., including several uranium and uranium/vanadium mining projects on standby and in various stages of permitting and development. The primary trading market for Energy Fuels’ common shares is the NYSE American under the trading symbol UUUU; the company’s common shares are also listed on the Toronto Stock Exchange under the trading symbol EFR. For more information, visit the company’s website at www.EnergyFuels.com.
NOTE TO INVESTORS: The latest news and updates relating to UUUU are available in the company’s newsroom at http://nnw.fm/UUUU
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
NetworkNewsWire is part of the InvestorBrandNetwork.
Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT), a producer, developer and operator of augmented reality (“AR”) interactive entertainment games, toys and educational materials in China, today announced its partnership with Xiamen Xing Meng Wei Lai Culture Media Co. LTD (“Xing Meng Wei Lai”) , a leading Chinese multi-channel network (“MCN”) and internet content development agency, to build Direct-to-Consumer (“DTC”) social content marketing channels via short videos and live streaming. “Establishing a short video live streaming DTC sales model is a milestone for Blue Hat because it not only serves to increase our brand awareness, but also to broaden our market reach,” Xiaodong Chen, CEO of Blue Hat, stated in the news release. “We believe that combining the power of short video live streaming with the reach of standard e-commerce platforms will be an important driver of Blue Hat’s online sales looking forward. With our comprehensive online and offline sales network, we believe we are building future revenue growth for our products.”
To view the full press release, visit http://nnw.fm/Q8iFm
About Blue Hat
Blue Hat Interactive Entertainment Technology is a producer, developer and operator of AR interactive entertainment games and toys in China, including interactive educational materials, mobile games and toys with mobile game features. The Company’s interactive entertainment platform creates unique user experiences by connecting physical items to mobile devices, which creates a rich visual and interactive environment for users through the integration of real objects and virtual scenery. Distinguished by its own proprietary technology, Blue Hat aims to create an engaging, interactive and immersive community for its users. For more information, please visit the Company’s investor relations website at www.IR.BlueHatGroup.com.
NOTE TO INVESTORS: The latest news and updates relating to BHAT are available in the company’s newsroom at http://nnw.fm/BHAT
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
NetworkNewsWire is part of the InvestorBrandNetwork.
Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, today announced that the United States Adopted Names (“USAN”) Council has approved the non-proprietary name quaratusugene ozeplasmid for GPX-001, formerly called Oncoprex(TM) immunogene therapy, the Company’s lead drug candidate for non-small cell lung cancer (“NSCLC”). “The USAN’s adoption of our non-proprietary name is another step toward advancing our lead drug candidate, GPX-001 for non-small cell lung cancer, toward commercialization,” Rodney Varner, chairman and CEO of Genprex, stated in the news release. “We look forward to the adoption and rollout of a brand name for this drug as we continue to move along the development pathway. In the meantime, we’ve focused our branding efforts on our proprietary, non-viral nanoparticle delivery system with our recognized Oncoprex(TM) name. We believe this delivery system is a significant differentiator for GPX-001, as well as an important platform delivery system that could be used for additional drug candidates.”
To view the full press release, visit http://nnw.fm/sY7OR
About Genprex, Inc.
Genprex, Inc. is a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes. Genprex’s technologies are designed to administer disease-fighting genes to provide new treatment options for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex works with world-class institutions and collaborators to in-license and develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches. The Company’s lead product candidate, Oncoprex(TM), is being evaluated as a treatment for non-small cell lung cancer (“NSCLC”). Oncoprex has a multimodal mechanism of action that has been shown to interrupt cell signaling pathways that cause replication and proliferation of cancer cells; re-establish pathways for apoptosis, or programmed cell death, in cancer cells; and modulate the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance. In January 2020, the U.S. Food and Drug Administration granted Fast Track Designation for Oncoprex immunogene therapy for NSCLC in combination therapy with osimertinib (AstraZeneca’s Tagrisso(R)) for patients with EFGR mutations whose tumors progressed after treatment with osimertinib alone. For more information, please visit the company’s website at www.Genprex.com
NOTE TO INVESTORS: The latest news and updates relating to GNPX are available in the company’s newsroom at http://nnw.fm/GNPX
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
NetworkNewsWire is part of the InvestorBrandNetwork.
The coronavirus pandemic has dealt a massive blow to the economy, and experts say it will take years to recover to pre-pandemic levels. State governments ordered the closure of all non-essential businesses, coupled with social distancing and self-isolation to curb the spread of the virus, but these measures wreaked havoc on the economy. Several industries have been almost been brought to a standstill as the country waits for the virus to pass, resulting in millions of job losses. However, one industry that seems to be weathering the storm is cannabis.
Many states with legal cannabis programs declared the industry essential, allowing cannabis dispensaries to continue operations amid COVID-19 related shutdowns. In some states, home deliveries and curbside deliveries were also allowed to reduce contact between staff and customers. In the weeks leading up to the shutdowns, cannabis shops reported increased sales as customers stocked up for the coming weeks they would spend in self-isolation. And, as broader retail sales fell by double digits in April, cannabis sales stayed strong. According to data from BDS Analytics, some states reported higher numbers in April than in March when demand spiked.
In April, Oregon stood out among states that have legalized marijuana. According to data from BDS Analyitcs, there was a 40% sales growth in April versus 31% in March and 19% in January. States that have regulated medical marijuana programs but do not allow recreational marijuana had even stronger gains. Sales in Maryland doubled and in Arizona they jumped nearly 50%. Nevada’s cannabis industry is more dependent on tourism than other states, and it saw a 30% drop in sales.
The 20th of April, affectionately called 4/20, is the unofficial cannabis holiday, and it has seen increased sales in previous years. This year, however, the biggest pot celebration day fell smack dab in the middle of the coronavirus crisis, and sales weren’t as great as they could have been. In Colorado and California, sales were 62% and 55% above the year-to-date average respectively compared to 148% and 135% increases in 2019. According to data from Headset Inc., overall sales in Colorado, Nevada, Washington and California fell 22% from 2019.
According to wholesale cannabis marketplace LeafLink Inc., the average share of concentrate products (commonly found in vapes) increased 30% during the week after Father’s Day last year compared to the week before. However, the products that seem to generate more demand on Father’s Day were dad-friendly products like cannabis cigars, mocktails and resins. Surprisingly, lip balms saw a 79% jump while breath strips and sublinguals’ sales increased 55%.
This is likely to be seen by sector players like Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) as further proof of the economic benefits of having a regulated marijuana market.
About CNW420
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CNW420.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have questions or are you interested in working with CNW420? Ask our Editor
CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CNW420 is part of the InvestorBrandNetwork.
SRAX (NASDAQ: SRAX), a digital marketing and consumer data management technology company, today announced its entry into definitive securities purchase agreements led by existing institutional investors for the purchase and sale of an aggregate of $13 million senior secured convertible debentures at an above market fixed conversion price of $2.69. According to the update, the Company intends to use the proceeds to fund the rapid expansion of its investor intelligence, data analytics and communications platform, Sequire.
To view the full press release, visit http://nnw.fm/OY5fD
About SRAX
SRAX (NASDAQ: SRAX) is a digital marketing and consumer data management technology company. SRAX’s technology unlocks data for brands in the CPG, investor relations, luxury, and lifestyle verticals. Through its various platforms, SRAX is monetizing its data sets and growing multiple recurring revenue streams. BIGtoken is a consumer-managed data marketplace where people can own and earn from their data. The platform also provides advertisers and media companies access to transparent, verified consumer data to better reach and serve audiences. Sequire is a premier platform for investor intelligence and communication. Through Sequire, public companies can track their investors’ behaviors and trends and use those insights to engage current and potential investors across marketing channels. For more information on SRAX and its verticals, visit www.SRAX.com.
NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://nnw.fm/SRAX
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
NetworkNewsWire is part of the InvestorBrandNetwork.
- Trxade Group Inc. is a growing B2B pharmaceutical network that provides solutions to small healthcare businesses, care providers and medical patients through growing optimization of remote-access health services
- Amid the sweep of the global COVID-19 pandemic, Trxade Group has continued to build its vision of enabling the health industry to operate transparently and effectively even as the importance of changing remote-access medicine models grows
- Trxade Group recently began receiving research report coverage from investment services firm Taglich Brothers, Inc. as part of ongoing brand-building efforts
- The company also recently announced that experienced healthcare market advisory professional Ashton Maaraba has been named president of Trxade Group’s Bonum Health telemedicine practice and will guide new patient acquisition
Growing prescription drug delivery and healthcare services innovator Trxade Group (NASDAQ: MEDS) continues to nurture a brand built on the vision of officers intent on providing affordability, transparency and equal access to medical community patients through effective technology. The company recently announced that investment services firm Taglich Brothers, Inc. has begun providing coverage to Trxade through its research division (http://nnw.fm/sSOt8).
Trxade’s efforts to expand its network of independent pharmacies and empower them to better deliver medications regardless of competition from larger retail chains have resulted in an upswell of brand-building and marketing outreach during the past several months.
After Trxade’s acquisition of Internet drug outlet company Community Specialty Pharmacy, LLC, (http://nnw.fm/wrNq4) the company began building a remote-access “secure virtual examination room” for patient-physician consultation through a “Health Hub” initiative that partners with the company’s drug delivery services (http://nnw.fm/3mHKC).
Trxade then began listing its common stock on The NASDAQ Capital Market in February as part of its efforts to increase its visibility, stability and ability to attract new investment (http://nnw.fm/uTO4r), even as the novel coronavirus pandemic was beginning to make itself known throughout the world. Trxade helped respond to concerns about limited testing for the new virus by rolling out an FDA-approved rapid point-of-care skin prick test to help medical professionals triage patients with potential COVID symptoms (http://nnw.fm/0Oknn).
Trxade’s developments are helping to position the company to deliver value to the health care market in coming days as nations recover from their initial shock at seeing populations decimated by the pandemic and begin working with confidence on providing health solutions and solutions that address economic and lifestyle needs.
“We believe our platform will become even more important for our customers in the years to come. We have a clear vision of our strategy and the opportunities ahead and look forward to another successful year of growth,” Board Chairman and CEO Suren Ajjarapu stated earlier this year in a report on the company’s 2019 achievements (http://nnw.fm/jA8tM).
The Taglich Brothers coverage involves an agreement for Taglich to create and disseminate research reports on Trxade and its market. Trxade has paid for the initial two months, which will begin reporting in September, and will begin paying a monthly service amount for ongoing reporting after that initial period has expired.
Trxade also recently announced the appointment of former AshHealth healthcare market advisory firm President Ashton Maaraba as president of Trxade Group’s Bonum Health telemedicine practice.
Maaraba has over 20 years of experience in developing and directing strategic national sales, marketing and operating initiatives in ever-changing, dynamic environments, according to the company, and will work to help build long-term shareholder value by welcoming a growing number of patients under the Bonum Health Hub platform.
“Ashton is an intuitive leader with acute business acumen and expertise in channel development and market development,” Trxade Group CEO Suren Ajjarapu stated in describing the company’s forward strategy (http://nnw.fm/8hFn9). “I am confident in his ability to drive widespread adoption of Bonum Health amongst both employers seeking to provide unique healthcare perks to their workers as well as to individuals seeking a low-cost, convenient way to speak with a doctor.”
For more information, visit the company’s website at www.TrxadeGroup.com.
NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://nnw.fm/MEDS
About NetworkNewsWire
NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
NetworkNewsWire is part of the InvestorBrandNetwork.
Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, today announced that its CEO and Chairman, Rodney Varner, will be participating in a live interview with the “Big Biz Show,” an Emmy Award winning nationally syndicated TV and radio show, on Thursday, June 25. The Big Biz Show, seen and heard in over 100 million broadcast TV homes, 150 U.S. radio stations and in 175 countries, covers current business events, internet-related issues and other hot topics in the business world. Among several engaging topics, Varner will discuss how Genprex is bridging critical gaps in modern medicine by providing new treatment options to patients with cancer and diabetes
To view the full press release, visit http://nnw.fm/d7wER
About Genprex, Inc.
Genprex, Inc. is a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes. Genprex’s technologies are designed to administer disease-fighting genes to provide new treatment options for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex works with world-class institutions and collaborators to in-license and develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches. The Company’s lead product candidate, Oncoprex(TM), is being evaluated as a treatment for non-small cell lung cancer (“NSCLC”). Oncoprex has a multimodal mechanism of action that has been shown to interrupt cell signaling pathways that cause replication and proliferation of cancer cells; re-establish pathways for apoptosis, or programmed cell death, in cancer cells; and modulate the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance. In January 2020, the U.S. Food and Drug Administration granted Fast Track Designation for Oncoprex immunogene therapy for NSCLC in combination therapy with osimertinib (AstraZeneca’s Tagrisso(R)) for patients with EFGR mutations whose tumors progressed after treatment with osimertinib alone. For more information, please visit the company’s website at www.Genprex.com
NOTE TO INVESTORS: The latest news and updates relating to GNPX are available in the company’s newsroom at http://nnw.fm/GNPX
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
NetworkNewsWire is part of the InvestorBrandNetwork.
Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, today announced that it has been selected to be added to the Russell Microcap Index at the conclusion of the 2020 Russell indexes annual reconstitution. According to a preliminary list of additions posted June 5, 2020, Trxade Group’s membership will be effective after the U.S. market opens on June 29, 2020. Russell Microcap Index membership, which remains in place for one year, ensures automatic inclusion in the appropriate growth and value style indexes. “We are pleased to be added to the Russell Microcap Index, raising Trxade Group’s visibility and public awareness within the investment community,” Suren Ajjarapu, chairman and CEO of Trxade Group, stated in the news release. “This marks an exciting capital markets milestone in the growth and trajectory of our Company as we continue to execute upon our growth strategy and raise awareness about the Company throughout the investment community.”
To view the full press release, visit http://nnw.fm/G4g7X
About Trxade Group, Inc.
Headquartered in Tampa, Florida, Trxade Group, Inc. (NASDAQ: MEDS) is an integrated drug procurement, delivery and healthcare platform that fosters price transparency, thereby improving profit margins for both buyers and sellers of pharmaceuticals. Trxade Group operates across all 50 states with the central mission of making healthcare services affordable and accessible. Founded in 2010, Trxade Group is comprised of four synergistic operating platforms; (1) the Trxade B2B trading platform with 11,400 registered pharmacies, (2) Integra Pharma Solutions, Trxade Group’s virtual wholesale division, (3) the Bonum Health platform offering affordable telehealth services; and (4) the DelivMeds app, which coordinates a nationwide distribution network through independent pharmacies or mail order delivery. For additional information, please visit www.Trxade.com, www.DelivMeds.com and www.BonumHealth.com.
NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://nnw.fm/MEDS
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
NetworkNewsWire is part of the InvestorBrandNetwork.
For the past few years, the US has been stuck in a state of civil unrest, with millions of Americans protesting police brutality against unarmed black folk. Triggered by the tragic murder of George Floyd by a police officer on the streets of Minneapolis, the countrywide protests have forced lawmakers to start working on policing reform legislation. In Georgia, as part of a recently filed comprehensive bill, lawmakers added a provision to decriminalize low-level marijuana possession.
It’s no secret that the decades-long War on Drugs has had a disproportionate effect on the black community. Advocates for the legalization of marijuana have repeatedly stated that legalizing cannabis is the first step in reversing the damage done to such communities. Senate Democrats introduced the Georgia Justice Bill to coincide with the reconvening of the legislative session this week. It covers a wide range of issues such as racial profiling, police body cameras, demilitarizing law enforcement, and cannabis policy reform.
Presently, state law dictates that possession of up to one ounce of cannabis is a misdemeanor punishable by up to one year in jail and a maximum $1,000 fine. The provision to decriminalize low-level marijuana possession would require state law to be amended so that possession of up to half an ounce of marijuana would be a misdemeanor punishable by a maximum $300 fine without the threat of jail time. Possession of more than a half-ounce but less than two ounces would be punishable by up to a year in jail and a maximum $1,000 fine.
“We have long felt the anguish that many Americans of all races are now experiencing. Racism is deeply embedded in our criminal justice system and it has permeated our society. The videos of police brutality that we’ve all seen demonstrate that our system must be fixed and fixed now,” said Sen. Harold Jones II the Democratic Caucus Whip and original sponsor of the bill in a press release. A former prosecutor now in private practice, he has been a longtime proponent of reforming minor drug offenses. He argues that many marijuana possession charges are what lead to over-policing and many times result in injury and even death.
“Cannabis is used as a pretext for thousands of police stops that happen daily in communities of color. Removing cannabis as a justification for police interaction is a reform urgently needed to address systemic racism and abusive policing,” says Marijuana Policy Project State Policies Director Karen O’Keefe. “While the Georgia Justice Act’s provision to stop incarcerating individuals for simple possession of marijuana would prevent trauma, even broader reforms are needed to dramatically reduce police harassment that uses cannabis as an excuse. Decriminalization can reduce arrests dramatically, but for the number of demeaning searches and stops to reduce, legalization is needed.”
It would be interesting to hear what established marijuana companies like Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) think about the nationwide ramifications if Georgia enacted this bill into law.
About CNW420
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CNW420.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have questions or are you interested in working with CNW420? Ask our Editor
CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CNW420 is part of the InvestorBrandNetwork.
- UUUU will pay off half of its debt in July, plans to be debt free by the end of 2020
- Expects to save about $350,000 in avoided interest
- Energy Fuels has focused on strategy to eliminate debt over the past several years with minimal impact to shareholders
Energy Fuels (NYSE American: UUUU) (TSX: EFR), the largest uranium mining company in the United States, plans to take a significant step forward in its strategy to reduce debt and further strengthen its balance sheet by redeeming half of its outstanding debt earlier than planned (http://nnw.fm/eAj5w). The company notified holders of the outstanding floating rate convertible unsecured subordinated debentures of its plans earlier this month.
“Energy Fuels is proud to announce that we are paying off half of our debt on July 14, 2020, and that we expect to become debt-free by the end of 2020,” said Energy Fuels president and CEO Mark S. Chalmers. “We are proactively managing our remaining debt to ensure we have the ability to pay it off on our own timing and terms and with minimal disruption. We believe it makes sense to redeem half of the Debentures now because the U.S.-Canada exchange rate is favorable, we have sufficient cash available, and we will avoid approximately US$350,000 in interest payments in 2020 by doing so. We will address the remaining Cdn$10,430,000 balance over the next several months when we think the timing is most appropriate.”
On July 14, 2020, UUUU will redeem the principal amount of Cdn$10,430,000, half of the outstanding Cdn$20,860,000 debentures, originally due Dec. 31, 2020. The debentures are redeemable for an amount equal to 101% of the principal due, plus accrued and unpaid interest thereon, up to but excluding the redemption date.
The plan calls for the debentures to be redeemed on a pro rata basis to the nearest multiple of Cdn$1,000 in accordance with the principal amount of the debentures registered in the name of each holder, or in such other manner as deemed equitable, subject to any applicable regulatory approvals. The record date for determining the holders of the debentures to be redeemed is slated for July 8, 2020. Following the partial redemption, Cdn$10,430,000 aggregate principal amount of the debentures will remain outstanding and shall continue to be subject to the terms of the indenture and remain listed on the Toronto Stock Exchange.
“Many junior uranium producers and developers in North America are currently incurring significant amounts of debt to fund exploration and development activities and to cover corporate overheads,” Chalmers said. “However, without sufficient cash flow, servicing this debt can become extremely burdensome and destructive to shareholder value. Instead, Energy Fuels has focused on a strategy to reduce our debt load over the past several years, including paying off our debt to the State of Wyoming in 2018, all with minimal impact to our shareholders. Furthermore, we do not expect to incur more debt in the future without a clear, short-term path toward positive cash flow. We will continue to manage all aspects of our business proactively, including maintaining our position as the leading U.S. uranium producer, advancing our exciting rare earth initiatives, and maintaining the other significant aspects of our business plan, including our significant inventories of uranium and vanadium.”
Based in Lakewood, Colorado, Energy Fuels holds three of America’s key uranium production centers: the Nichols Ranch (“ISR”) project in Wyoming, the Alta Mesa ISR Project in Texas, and the White Mesa Mill in Utah — the only conventional uranium mill operating in the U.S. today with a licensed capacity of more than 8 million pounds of U3O8 per year. With an asset portfolio that boasts more uranium production facilities, in-ground resources, and production capacity than any other producer, Energy Fuels is in a unique position to take charge as the leading producer of uranium in an era of viable transformation of the U.S. nuclear industry. Energy Fuels is also making significant progress in entering the U.S. rare earth processing business.
For more information, visit the company’s website at www.EnergyFuels.com.
NOTE TO INVESTORS: The latest news and updates relating to UUUU are available in the company’s newsroom at http://nnw.fm/UUUU
About NetworkNewsWire
NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
NetworkNewsWire is part of the InvestorBrandNetwork.
Canopy Rivers (TSX: RIV) (OTC: CNPOF) on Monday announced that the most recent addition to its portfolio of disruptive cannabis companies, Dynaleo Inc., has received its Standard Processing License from Health Canada. According to the update, this follows the completion and commissioning of Dynaleo’s 27,000 square foot purpose-built facility and is a key milestone as it aims to ramp up production of white label gummies for the Canadian recreational market. “We are thrilled with the momentum at Dynaleo,” Narbé Alexandrian, president and CEO of Canopy Rivers, stated in the news release. “Data shows that the total addressable market for edibles, and specifically gummies, remains large. Licensed producers haven’t yet been able to scale their production to meet consumer demand for this product category, and brand loyalty has not yet been achieved the same way we have seen in mature U.S. markets for similar products. We believe that Dynaleo will be a key partner in manufacturing gummies brands that will be leaders in the 2.0 market.”
To view the full press release, visit http://cnw.fm/ZahY8
About Canopy Rivers
Canopy Rivers is a venture capital firm specializing in cannabis with a portfolio of 18 companies across various segments of the cannabis value chain. Canopy Rivers believes that bringing together people, capital and ideas raises the potential of the entire cannabis industry. By leveraging its industry insights, in-house expertise, and thesis-driven approach to investing, Canopy Rivers aims to provide shareholders with exposure to specialized and disruptive cannabis companies. The company’s mission is to invest in innovators across the cannabis value chain, help them grow, and ultimately create value by guiding these companies towards a monetization event. Together with its portfolio, Canopy Rivers is helping build the cannabis industry of tomorrow, today. For more information, visit www.CanopyRivers.com.
NOTE TO INVESTORS: The latest news and updates relating to CNPOF are available in the company’s newsroom at http://cnw.fm/CNPOF
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CannabisNewsWire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have questions or are you interested in working with CNW? Ask our Editor
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CannabisNewsWire is part of the InvestorBrandNetwork.
Wrap Technologies (NASDAQ: WRTC), an innovator of modern policing solutions, today announced its receipt of more than 100 requests for BolaWrap demonstrations and training in the last month. According to the update, an additional 36 agencies have applied for grant assistance since the June 4 debut of the Grant Assistance Program. “Agencies have been reevaluating their use of force methods and tools during encounters with subjects who need to be detained,” Wrap Technologies Chief Operating Officer Mike Rothans said in the news release. “BolaWrap is at the forefront of conversations, as our remote restraint device is the only tool on an officer’s belt designed to restrain a noncompliant subject without inflicting pain.”
To view the full press release, visit http://nnw.fm/Sym1X
About Wrap Technologies (NASDAQ: WRTC)
Wrap Technologies is an innovator of modern policing solutions. The Company’s BolaWrap 100 product is a patented, hand-held remote restraint device that discharges an eight-foot bola style Kevlar(R) tether to restrain an individual at a range of 10-25 feet. Developed by award winning inventor Elwood Norris, the Company’s Chief Technology Officer, the small but powerful BolaWrap 100 assists law enforcement to safely and effectively control encounters, especially those involving an individual experiencing a mental crisis. For information on the Company please visit www.WrapTechnologies.com. Examples of recent media coverage are available as links under the “Media” tab of the website.
NOTE TO INVESTORS: The latest news and updates relating to WRTC are available in the company’s newsroom at http://nnw.fm/WRTC
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
NetworkNewsWire is part of the InvestorBrandNetwork.
- App will allow company executives to monitor shareholders’ trading behavior from any location
- Platform enables diverse account management capabilities, including ability to build contact profiles on shareholders, track outstanding warrants and shares, manage social media & news campaigns remotely
- Online modes of connecting with investors have become especially relevant in wake of COVID-19 pandemic
SRAX (NASDAQ: SRAX), a digital marketing pioneer focused on providing consumer data management services, has recently launched a new app for its investor intelligence platform, Sequire. Sequire, which enables companies to monitor their shareholders’ buying and selling behavior and interact with them through a number of digital mediums, has seen a rapid gain in adherents following the onset of the COVID-19 pandemic, which has caused demand for virtual investor relations platforms and services to skyrocket. Now through the launch of its proprietary mobile application, Sequire will allow CEOs & CFOs of public companies to monitor their investors’ trading behaviors anywhere they go.
The application, which is available to download for free on the App Store and Google Play, includes many of the features which have been popularized through the Company’s existing service. Subscribers will now be able to gain insights on their shareholder’s trading activity, analyze market-maker activity within their listed equities through the use of level 2 trading data and even turn real-time conference visitor data into targeted cross-channel ads. The app will also provide users with a business card scanner, enabling executives to quickly scan business cards to save and organize contact information from people they meet.
“We are thrilled to launch the Sequire mobile app enabling our clients to now monitor their investors’ behaviors and their contributions anytime and anywhere,” says SRAX CEO and founder Christopher Miglino (http://nnw.fm/p5v1M). “We’ll also be launching more exciting mobile features in the next few months, so stay tuned.”
Investor relations functions have increasingly gone digital as companies find themselves unable to meet with their investors in person. Hundreds of investor conferences across the world have been moved to virtual platforms while webinars have gained in popularity—the latter medium allowing presenters to target and reach far wider audiences than ever before. However the shift to digital mediums has been juxtaposed against record trading volumes and market volatility, with monthly equity transactions hitting historic highs across a multitude of global stock exchanges in the first quarter (http://nnw.fm/iUh0A). As investors have sought to gain greater clarity on corporate prospects during these uncertain times, virtual IR platforms such as SRAX Inc’s Sequire have found themselves in greater demand than ever before.
For more information, visit the company’s website at www.SRAX.com.
NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://nnw.fm/SRAX
About NetworkNewsWire
NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
NetworkNewsWire is part of the InvestorBrandNetwork.
Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, is building a parallel network to healthcare chains such as Walgreens or CVS by bringing together independent pharmacies across the country under its technology and by offering a promise of same-day delivery. The company, which was recently uplisted to Nasdaq, has been bringing together independent pharmacies under one umbrella through its web-based purchasing platform and is now present in all 50 states and rapidly adding 100-150 pharmacies every month. In an interview with AlphaStreet, Trxade CEO Suren Ajjarapu said the company’s focus is to empower independent pharmacies to compete with bigger healthcare retailers such as CVS Health (NYSE: CVS) or Walgreens Boots Alliance (NASDAQ: WBA) by helping them achieve same-day delivery of drugs. “If you look at the telemedicine portals, those scripts are walking into the Walgreens and CVS,” Suren said in the interview. “We want to see whether we can take these scripts to the independents. By giving them business, they will buy more from us. So that’s the strategy.”
To view the full article, visit http://nnw.fm/F9Mlw
About Trxade Group, Inc.
Headquartered in Tampa, Florida, Trxade Group, Inc. (NASDAQ: MEDS) is an integrated drug procurement, delivery and healthcare platform that fosters price transparency, thereby improving profit margins for both buyers and sellers of pharmaceuticals. Trxade Group operates across all 50 states with the central mission of making healthcare services affordable and accessible. Founded in 2010, Trxade Group is comprised of four synergistic operating platforms; (1) the Trxade B2B trading platform with 11,400 registered pharmacies, (2) Integra Pharma Solutions, Trxade Group’s virtual wholesale division, (3) the Bonum Health platform offering affordable telehealth services; and (4) the DelivMeds app, which coordinates a nationwide distribution network through independent pharmacies or mail order delivery. For additional information, please visit www.Trxade.com, www.DelivMeds.com and www.BonumHealth.com.
NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://nnw.fm/MEDS
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
NetworkNewsWire is part of the InvestorBrandNetwork.
Last week, Governor John Bel Edwards signed a bill that will allow Louisiana residents to get medical marijuana for any debilitating condition their doctors see fit. Sponsored by Rep. Larry Bagley, the medical marijuana expansion bill significantly expands beyond the 14 specific medical conditions that qualify patients for medical cannabis. As of August 1, patients will be able to purchase medical marijuana as long as they have a condition deemed by their doctor as debilitating.
Originally, the marijuana expansion bill would only have added traumatic brain injuries and concussions as qualifying conditions. However, it was amended in committee to include several other medical conditions as well as language stipulating that cannabis can be recommended for any medical condition that a doctor “considers debilitating to an individual patient and is qualified through his or her medical education and training to treat.”
“This is a common-sense legislation that provides physicians, not lawmakers, the ability and discretion to decide what treatment options are best for patients. Just as doctors are entrusted to make decisions with regard to the supervised use of opiates and other medicines, many of which pose far greater risks to patients than cannabis, the law should provide doctors with similar flexibility when it comes to recommending cannabis therapy to a bona fide patient,” says National Organization for the Reform of Marijuana Laws (NORML) Deputy Director Paul Armentano.
Rep. Bagley had introduced a House-passed bill alongside the expansion legislation to allow delivery services, but he voluntarily withdrew it from Senate committee consideration. He stated that he believed the marijuana expansion bill would already allow cannabis products to be delivered to qualifying patients like other traditional pharmaceuticals. Whether regulators will agree with his interpretation of the law is unclear.
The governor also signed legislation that would protect banks, credit unions and other financial institutions that work with cannabis businesses from being penalized by state regulators as well as a bill to provide immunity from prosecution to doctors who recommend medical marijuana to their patients and “any facility that is licensed by the Louisiana Department of Health that has patients in its care using medical cannabis.”
Once the cannabis expansion bill takes effect, Louisiana will join a handful of states such as Maine, California, and Virginia that have enacted similar measures granting licensed doctors the ability to recommend medical cannabis as a treatment to any patient they believe has a qualifying condition.
Analysts say companies like Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) would like to see the U.S. federal government also take more progressive steps on matters of marijuana.
About CNW420
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CNW420.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have questions or are you interested in working with CNW420? Ask our Editor
CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CNW420 is part of the InvestorBrandNetwork.
Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery, and healthcare platform, on Monday announced that management will deliver a virtual presentation at 11:30 a.m. Eastern Time on Wednesday, June 24, 2020. According to the update, Trxade CEO Suren Ajjarapu will present an overview of the business model and growth initiatives of the company during the webinar, which will be followed with a question and answer session. Interested parties may access the webinar by dialing 1-877-425-9470 or 1-201-389-0878 (International) and entering conference code: 13705066. To register and log into the webcast, visit http://nnw.fm/0mrhR
To view the full press release, visit http://nnw.fm/5sMPk
About Trxade Group, Inc.
Headquartered in Tampa, Florida, Trxade Group, Inc. (NASDAQ: MEDS) is an integrated drug procurement, delivery and healthcare platform that fosters price transparency, thereby improving profit margins for both buyers and sellers of pharmaceuticals. Trxade Group operates across all 50 states with the central mission of making healthcare services affordable and accessible. Founded in 2010, Trxade Group is comprised of four synergistic operating platforms; (1) the Trxade B2B trading platform with 11,400 registered pharmacies, (2) Integra Pharma Solutions, Trxade Group’s virtual wholesale division, (3) the Bonum Health platform offering affordable telehealth services; and (4) the DelivMeds app, which coordinates a nationwide distribution network through independent pharmacies or mail order delivery. For additional information, please visit www.Trxade.com, www.DelivMeds.com and www.BonumHealth.com.
NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://nnw.fm/MEDS
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
NetworkNewsWire is part of the InvestorBrandNetwork.